Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1 clinical trials
Evaluate the Safety and Tolerability for Nirsevimab in Immunocompromised Children

Study D5290C00008 is a Phase 2, open-label, uncontrolled, single-dose study to evaluate the safety and tolerability, PK, occurrence of ADA, and efficacy of nirsevimab in immunocompromised Japanese children who are 24 months of age at the time of dose administration. Approximately 30 subjects will be enrolled. Subjects will be followed …

HIV Infection
wiskott-aldrich syndrome
corticosteroid therapy
methotrexate
immunodeficiency
  • 15 views
  • 20 Jul, 2021
  • 9 locations